Brandywine Global Investment Management LLC Boosts Stock Holdings in DaVita Inc. (NYSE:DVA)

Brandywine Global Investment Management LLC grew its position in DaVita Inc. (NYSE:DVA) by 68.5% during the 4th quarter, HoldingsChannel.com reports. The fund owned 108,272 shares of the company’s stock after buying an additional 44,005 shares during the quarter. Brandywine Global Investment Management LLC’s holdings in DaVita were worth $16,192,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. SBI Securities Co. Ltd. acquired a new stake in DaVita during the 4th quarter worth $41,000. Quarry LP purchased a new position in shares of DaVita in the third quarter worth about $60,000. Venturi Wealth Management LLC boosted its position in DaVita by 59.8% during the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock worth $61,000 after acquiring an additional 152 shares during the last quarter. Versant Capital Management Inc grew its stake in DaVita by 58.7% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after acquiring an additional 169 shares in the last quarter. Finally, Blue Trust Inc. raised its holdings in DaVita by 39.7% in the 4th quarter. Blue Trust Inc. now owns 461 shares of the company’s stock valued at $76,000 after acquiring an additional 131 shares during the last quarter. 90.12% of the stock is owned by institutional investors and hedge funds.

DaVita Stock Performance

Shares of DaVita stock opened at $150.29 on Monday. The business’s fifty day simple moving average is $157.39 and its 200-day simple moving average is $157.55. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The firm has a market cap of $12.02 billion, a PE ratio of 13.99, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99. DaVita Inc. has a 52 week low of $125.64 and a 52 week high of $179.60.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Equities analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current year.

Wall Street Analyst Weigh In

DVA has been the subject of a number of analyst reports. Sanford C. Bernstein set a $184.00 price target on DaVita in a research report on Friday, February 21st. StockNews.com lowered DaVita from a “buy” rating to a “hold” rating in a research note on Friday, March 21st. Cowen reiterated a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. Finally, Barclays upped their price objective on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a report on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.